FHIR Cross-version Mappings for ClinicalUseDefinition based on the R5 structure
| ClinicalUseDefinition (4.3.0) | ClinicalUseDefinition (5.0.0) | |
|---|---|---|
| ClinicalUseDefinition | = | ClinicalUseDefinition |
| = | ||
| ☰ | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| = | ||
| R4B ClinicalUseDefinition.type | R5 ClinicalUseDefinition.type | |
| indication | = | indication |
| contraindication | = | contraindication |
| interaction | = | interaction |
| undesirable-effect | = | undesirable-effect |
| warning | = | warning |